SINGLETON J MATTHEW received a stock award from VIKING THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2026ACC: 0001193125-26-003112
Director
Since Jan 2019
+23.55K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
23.55K acquired
Non-Derivative Transactions1
Common Stock, par value $0.00001 per share
Direct
Shares
+3.15K
Price / share
—
Trade value
—
% of position
33.2%
1/2/2026
9.50K→12.65K
Total
Net shares
+3.15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 1/2/2026 | A · Award | +3.15K | — | — | 33.2% | 9.50K | 12.65K |
| Total | +3.15K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
20.40K shares
Shares
+20.40K
Strike price
35.42
Held after
20.40K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock20.40K shares | 1/2/2026 | A · Award | +20.40K | 35.42 | — | 20.40K |